FOLH1 and neoplasm: Prostate-specific membrane antigen (PSMA) probes conjugated with ALB not only enhance stability in circulation but also improve tumor accumulation, providing robust support for early PCa diagnosis, treatment monitoring, and targeted therapy (49).